Therapeutic effects of sericin on diabetic keratopathy in Otsuka Long-Evans Tokushima Fatty rats

doi:10.4239/wjd.v4.i6.282

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6634)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

432

WORD

305

HTML

3621

Figures (1-6)

279

Tables (1-1)

227

Sum=4864

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

859

Download

910

Sum=1769

Dec 15, 2013 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Diabetes. Dec 15, 2013; 4(6): 282-289
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.282

Full Size Figure Download Figure

Figure 1 Picture of sericin and protocol in this study. A: Picture of sericin; B: Picture of sericin solution. The sericin solutions used in this study were prepared by adding sericin to saline (pH 6.5-7.5); C: Protocol for instillation of sericin. Saline, sericin or hyaluronic acid solutions were instilled into the eyes of rats five times a day.

Citation: Nagai N, Ito Y. Therapeutic effects of sericin on diabetic keratopathy in Otsuka Long-Evans Tokushima Fatty rats. World J Diabetes 2013; 4(6): 282-289
URL: https://www.wjgnet.com/1948-9358/full/v4/i6/282.htm
DOI: https://dx.doi.org/10.4239/wjd.v4.i6.282